The British Columbia Securities Commission declined to unwind Zefiro Methane Corp.’s debt-settlement share issue or prevent the recipients from voting, finding that urgent financing needs and the absence of a reasonable alternative outweighed concerns about interference in a proxy contest.

In Re Zefiro Methane Corp., 2026 BCSECCOM 334, reasons dated October 5, 2026, the commission explained its March 6 dismissal of both the shareholders’ application and a competing application to restrict their voting rights. The panel consisted of vice-chair Gordon Johnson and commissioners Marion Shaw and Douglas Seppala.

The ruling was not a finding that the financing was free of defensive motives. Zefiro failed to establish that the transaction was clearly not a defensive tactic. But the panel found no clear abuse of shareholders or capital markets after weighing the company’s financial position against shareholder choice.

A financing dispute inside a contest for control

Former chief executive Talal Debs and two X Machina entities challenged shares issued to Catherine Flax, David McGrath and Michael McGavick. Their February application alleged a series of steps designed to entrench Zefiro’s board, including Debs’s removal as CEO, the treatment of investor participation rights and share issues that diluted the applicants’ influence. The requested relief ultimately focused on rescinding the debt-settlement shares or preventing their use at the impending shareholder meeting.

Zefiro, a British Columbia company providing environmental services involving oil and gas wells and pipelines, had encountered serious financing problems before the proxy contest began. It missed repayment of a US$2-million note in May 2025 and risked losing the subsidiary that supplied its core business and principal income. A group of investors then lent it US$2.48 million at an annual interest rate of 18 per cent, with accompanying share-purchase warrants.

Debs was removed as CEO in June 2025, and Flax became interim CEO. In October, Debs announced his intention to nominate an alternative slate of directors. Meanwhile, management continued looking for financing and considering whether existing warrant holders could be encouraged to exercise their rights and provide liquidity.

The eventual arrangement involved the exercise of warrants to acquire 10,790,000 shares at 23 cents each, with 75 per cent of the proceeds set off against debt. Zefiro also issued 1,409,589 shares to settle the remaining debt owed to the participating investors and another 1,014,905 shares to compensate for interest they would forgo through early repayment. The dispute concerned those incentives and the surrounding transaction, not simply investors exercising existing warrants on their own initiative.

The applicants argued that the terms were overly favourable to investors aligned with management and were implemented just before the voting record date. They asked the panel to consider the broader context, including change-of-control payments, an amended nomination policy and the publicizing of allegations against Debs. Zefiro answered that conventional financing had proved unavailable, the existing lenders needed an incentive to exchange their positions for risky equity, and further delay would have been irresponsible.

Two stages, not an automatic prohibition

The application invoked section 114 of British Columbia’s Securities Act. That provision permits public-interest orders including rescinding a securities transaction and prohibiting the exercise of voting rights. No specific breach of the Act was alleged. The panel emphasized that public-interest powers protect investors and fair, efficient markets; they are not a means of punishment and must be exercised cautiously where conduct is not expressly prohibited.

The commission adapted the framework developed in Hecla, extended to proxy contests in Eco Oro and applied in Mithaq. Although National Policy 62-202 concerns defensive tactics in takeover bids, its shareholder-choice principles also inform review of transactions affecting a contested vote for directors.

The first question was whether the share issue was clearly not a defensive tactic. The applicants initially had to show at least uncertainty on that point. They met that burden through evidence of steps intended to prevent Debs from regaining managerial control. Because the material effect of the share issue on the vote was disputed, the panel assumed materiality for its analysis rather than deciding that issue, placing the burden on Zefiro to show the transaction was clearly non-defensive.

The evidence pointed in different directions. Zefiro’s serious and immediate financing need favoured its position, as did efforts to obtain investment from warrant holders before the proxy contest. But the details of the substantial inducements emerged only in early 2026. Other conduct indicating a wish to exclude Debs was inconsistent with leaving the choice of management to shareholders. Taken together, those factors meant Zefiro could not clear the first stage.

The panel also treated governance and the handling of related-party conflicts as relevant. It said it could find fault with Zefiro’s management of potential conflicts, but other factors carried more weight in this case. The result did not amount to unqualified approval of the company’s process.

That did not end the analysis. At the second stage, the question was whether the share issue amounted to a clear abuse of shareholders or capital markets. The panel balanced the financing’s benefits against its effect on voting and the relationships between the participating investors and management.

Why the financing need prevailed

The commission found that Zefiro had searched extensively and in good faith for alternatives. It acknowledged that much of the chief financial officer’s evidence was conclusory and had been tested effectively in cross-examination. Nevertheless, contemporaneous communications, the company’s financial difficulties, corroborating evidence and the absence of an alternative identified by Debs supported management’s account. Cboe’s review and approval of the issue was another supporting factor, not the sole basis for the conclusion.

A January restructuring memorandum had adequately described the essential transaction. Debs’s response supporting deleveraging in general was not consent to the transaction, the panel said, but it showed that he had not proposed an alternative at that critical stage. He later voted against the agreement; the other attending directors, including three independent directors, approved it.

The applicants’ strongest suggested alternative was to wait and see whether lenders would exercise their warrants without incentives. The panel rejected that course because the lenders had no obligation to do so. Without their participation, Zefiro would likely have defaulted on a separate $1-million payment due March 1, worsening its already difficult access to funds.

The panel accepted that an existing need for significant financing over the next 12 months could be immediate. Here, it found the adopted transaction was the only reasonable option. That conclusion was decisive: even assuming a material effect on the vote, the benefit to shareholders from meeting the urgent financing need outweighed the concerns about management-aligned investors. The commission saw no other public-interest basis to intervene.

Competing voting claim left to the courts

McGrath’s cross-application sought to prevent Debs and the X Machina entities from voting certain shares, relying on alleged fiduciary and partnership duties and a side-letter. The commission had initially stayed part of that claim while allowing further argument about its jurisdiction.

In dismissing the cross-application, the panel characterized the fiduciary-duty allegations as corporate-law issues. Although the Securities Act provides potentially useful remedies, the panel said those remedies should address securities-law issues. Even if jurisdiction existed for the requested purposes, intervention would not be in the public interest: the commission had only a sampling of the evidence, while the issues were already before courts able to obtain the necessary facts.

The reasons therefore preserve two limits. A financing transaction does not escape scrutiny merely because the company needs money, and evidence of a defensive purpose does not automatically require unwinding it. The outcome turned on the proven financing circumstances and the absence of reasonable alternatives, not a general licence to dilute dissident shareholders during a proxy contest.